Midazolam and Its Effect on Vital Signs and Behavior in Children Under Conscious Sedation in Dentistry

Abstract

Midazolam is a short acting sedative with small number of adverse effects. Administered orally, it is currently the most common form of conscious sedation in children. The objective of this paper is to describe effect of midazolam administered to children during dental treatment on their vital signs, and to monitor changes in children’s behavior. We described values of vital signs and behavior in 418 sedations conducted in 272 children between 1-12 years of age. To achieve the following results, we used data from 272 all first-time sedations. After administration of midazolam arterial blood pressure and blood oxygen saturation decreased by values which were not clinically significant. The heart rate increased, with values staying within the limits of physiological range. The speed of onset of midazolam’s clinical effects depends on age and dose. The lower age and dose correlated with the higher behavior score. The effectiveness of midazolam treatment is 97.8 %. Unwillingness of child to receive midazolam is predictor for disruptive behavior during sedation. 1.8 % of all sedation cases showed paradoxical reactions. The administration of midazolam in dose of 0.5 mg per 1 kg of child’s body weight is safe and could be recommended for dental treatment in pediatric dentistry.

Success rate of nitrous oxide-oxygen procedural sedation in dental patients: systematic review and meta-analysis

“…Scientific literature describes a wide range of other success criteria, some of which were used in the included RCTs, such as the Ramsay Sedation Scale [ 86 ] or Richmond Agitation-Sedation Scale [ 87 ]. Some methods are based on physiological parameters, such as the bispectral index system [ 88 ] or the evaluation of serum cortisol levels [ 89 ] and vital signs [ 90 91 ].…”

Sedation in pediatric dentistry: A scoping review

“…It is possible that midazolam may present adverse reactions such as disinhibition, hallucinations, agitation, inconsolable crying, restlessness and disorientation, especially in young children, accounting for 1.4% of cases [24] . It is contraindicated in patients with pulmonary disease and who are sensitive to benzodiazepines [25] .…”

Use of Midazolam in Paediatric Dentistry

“…Midazolam má při dodržení doporučených dávek minimální riziko závažného poklesu funkce dýchacího [1] a kardiovaskulárního systému [15]. Dýchací systém ovlivňuje midazolam snížením svalového tonu při myorelaxaci, která může vést k obstrukci dýchacích cest, a snížením ventilační odezvy na oxid uhličitý.…”